Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-018-0368-3
Abstract: Keratosis pilaris is a common skin disorder comprising less common variants and rare subtypes, including keratosis pilaris rubra, erythromelanosis follicularis faciei et colli, and the spectrum of keratosis pilaris atrophicans. Data, and critical analysis of… read more here.
Keywords: subtypes associations; pilaris subtypes; keratosis; keratosis pilaris ... See more keywords
Clinical and Dermoscopic Evaluation of Trichloroacetic Acid 20% Versus Long-Pulsed 1064-nm Nd-YAG Laser in the Treatment of Keratosis Pilaris
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000003488
Abstract: BACKGROUND Keratosis pilaris (KP) is a common disorder of keratinization with different therapeutic modalities; however, none of them is completely satisfactory. OBJECTIVE Assess and compare the efficacy of trichloroacetic acid (TCA) 20% and long-pulsed 1,064-nm… read more here.
Keywords: improvement; long pulsed; dermoscopic; treatment ... See more keywords
Mutation and expression of ABCA12 in keratosis pilaris and nevus comedonicus
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2018.9342
Abstract: Keratosis pilaris (KP) and nevus comedonicus (NC) are congenital keratinized dermatoses; however, the exact etiology of these two diseases is unclear. The objective of the present study was to identify the disease-causing genes and their… read more here.
Keywords: expression; keratosis pilaris; nevus comedonicus; pilaris nevus ... See more keywords
Nilotinib-induced Keratosis Pilaris Associated with Alopecia Areata and Eyebrow Thinning
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Trichology"
DOI: 10.4103/ijt.ijt_1_17
Abstract: Tyrosine kinase enzymes are an attractive target for anticancer therapies. Tyrosine kinase inhibitors (TKI) are well tolerated; somehow severe systemic side effects are rarely seen during treatment. Toxicities of skin and appendages may lead to… read more here.
Keywords: alopecia areata; nilotinib induced; associated alopecia; keratosis pilaris ... See more keywords